230. Understanding GLP-1 Agonists: Addressing the Myth of Non-Responsiveness

"It's not that we have non-responders. It's that we have unrealistic expectations." - 00:20:38

Part 2: Addressing the Myth of Non-Responsiveness

A Personal Insight from Greece: Aligning Your Environment with Your Energy

Dr. Novitsky begins by sharing a story from her trip to Greece, where the simplicity of her surroundings inspired her to declutter her home. This serves as a metaphor for aligning one's environment with their energy and current needs.

Common Concerns About GLP-1 Agonists

Dr. Novitsky discusses why people often struggle with GLP-1 agonists. Two main reasons stand out: confusion over how to balance medication with nutrition and exercise, often accompanied by shame, and the belief that they are "non-responders" to the medication.

How a Nutrition Audit Can Help

For those who feel they are non-responders, Dr. Novitsky introduces the concept of a nutrition audit. By tracking food intake without changes for a week, clients can gather data on calories, protein, carbs, fat, fiber, and added sugars. This helps uncover what might be hindering progress.

The Importance of Caloric Deficits and BMR

Dr. Novitsky explains that GLP-1 agonists don't guarantee weight loss. Weight loss still requires a caloric deficit, which means consuming fewer calories than one's basal metabolic rate (BMR). Many mistakenly believe they’re in a deficit when they’re not, leading to frustration.

Leptin Resistance and Weight Loss Struggles

The episode dives into leptin resistance, a condition that can make weight loss harder, even when someone is consuming fewer calories. Leptin plays a role in hunger and metabolism, and resistance to it may be a reason some struggle with weight loss.

Patience and Realistic Expectations

Dr. Novitsky stresses patience when using GLP-1 agonists, explaining that weight loss varies by individual. Inflammation, body composition, and initial body fat all play a role in determining how quickly one may lose weight. She advises setting realistic goals to avoid discouragement.

Looking Ahead

Dr. Novitsky wraps up by encouraging listeners to reflect on their own journey, asking them to consider if any of the factors discussed apply to their experience. She teases upcoming episodes that will provide further insights into GLP-1 agonists and weight loss strategies.

  Listen to Episode 230 Here

Or listen on your favorite podcast app: Apple Podcasts | Spotify | Android

Chapters 

(00:02) Introduction and personal story about GLP-1  
(07:45) Common misconceptions about GLP-1 agonists  
(15:30) History of GLP-1 agonists and their use in diabetes  
(22:10) How GLP-1 agonists support weight loss  
(28:35) Criteria for GLP-1 candidacy beyond BMI  
(33:50) Addressing side effects and pharmaceutical involvement  
(39:12) Importance of lifestyle changes with medication  
(46:20) Looking ahead: Microdose medications for longevity  
(52:15) Overview of Dr. Novitsky's coaching programs  
(56:40) Closing thoughts on compassion and holistic care

Resources:

*Ali Novitsky MD, this podcast, and podcast write-up are NOT providing medical advice. We do not recommend you start any exercise program without first consulting with your doctor!*

Previous
Previous

231. Breaking the Stigma: Can You Ever Stop GLP-1 Agonists After Weight Loss?

Next
Next

229. Understanding GLP-1 Agonists, Part 1: Evolution from Diabetes Treatment to Weight Loss